Tag Archives: reuters.com

GW to file cannabis drug as journal confirms epilepsy success | Reuters




LONDON GW Pharmaceuticals is set to file its cannabis-derived drug with U.S. regulators imminently, following publication of detailed data on its success in fighting severe childhood epilepsy.GW first reported in March 2016 that Epidiolex cut monthly convulsive seizures by 39 percent in children with Dravet syndrome, but full results of the 120-patient study were only published in the New England Journal of Medicine on Wednesday.The journal article also showed that 5 percent of patients stopped having seizures altogether and 43 percent saw their seizures cut by half.

Read More »